Poly(lactic-co-glycolic acid) (PLGA)
is used in vivo for various biomedical applications.
Due to its
biodegradability and biocompatibility, PLGA is uniquely suited for
controlled drug delivery with parenteral administration. Previously,
we established the synthesis of isotactic, alternating PLGA from enantiopure
starting materials. Here, to fill in the gap of the current field,
we have developed the synthesis of syndioenriched, alternating PLGA
from racemic methyl-glycolide (rac-MeG). The synthesis
of alternating PLGA is accomplished by a highly regioselective ring-opening
polymerization of rac-MeG with an optimized racemic
aluminum catalyst. Mechanistic studies are carried out to elucidate
the pairing-enhanced catalyst regio- and stereocontrol. Polymer sequence
fidelity has been established by NMR investigations, confirming a
high degree of alternation of the comonomer sequence and moderate
syndiotacticity within the backbone stereoconfiguration. The resulting
syndioenriched material is amorphous, which will facilitate the drug
complexation behavior